DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 16.16
(0.56%)
CNY 16.16
(0.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.03 CNY | 13.19% |
| 2022 | 0.91 CNY | 30.0% |
| 2021 | 0.70 CNY | -25.53% |
| 2020 | 0.94 CNY | 49.21% |
| 2019 | 0.63 CNY | 28.57% |
| 2018 | 0.49 CNY | 4.26% |
| 2017 | 0.47 CNY | 6.82% |
| 2016 | 0.44 CNY | -4.35% |
| 2015 | 0.46 CNY | 27.78% |
| 2014 | 0.36 CNY | 33.33% |
| 2013 | 0.27 CNY | -6.9% |
| 2012 | 0.29 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.23 CNY | -34.29% |
| 2024 Q1 | 0.35 CNY | 5172.46% |
| 2024 Q3 | 0.18 CNY | -21.74% |
| 2023 Q4 | -0.01 CNY | -103.0% |
| 2023 Q1 | 0.44 CNY | 214.29% |
| 2023 Q2 | 0.37 CNY | -15.91% |
| 2023 FY | - CNY | 13.19% |
| 2023 Q3 | 0.23 CNY | -37.84% |
| 2022 Q2 | 0.42 CNY | 2.44% |
| 2022 FY | - CNY | 30.0% |
| 2022 Q4 | 0.14 CNY | -48.15% |
| 2022 Q3 | 0.27 CNY | -35.71% |
| 2022 Q1 | 0.41 CNY | 1759.92% |
| 2021 Q1 | 0.30 CNY | 20.0% |
| 2021 Q3 | 0.22 CNY | -43.59% |
| 2021 FY | - CNY | -25.53% |
| 2021 Q2 | 0.39 CNY | 30.0% |
| 2021 Q4 | -0.02 CNY | -111.23% |
| 2020 Q3 | 0.24 CNY | -40.0% |
| 2020 Q2 | 0.40 CNY | 60.0% |
| 2020 FY | - CNY | 49.21% |
| 2020 Q1 | 0.25 CNY | 25.0% |
| 2020 Q4 | 0.25 CNY | 4.17% |
| 2019 FY | - CNY | 28.57% |
| 2019 Q3 | 0.16 CNY | -38.46% |
| 2019 Q4 | 0.20 CNY | 25.0% |
| 2019 Q1 | 0.22 CNY | 37.5% |
| 2019 Q2 | 0.26 CNY | 18.18% |
| 2018 Q1 | 0.14 CNY | -6.67% |
| 2018 Q4 | 0.16 CNY | 6.67% |
| 2018 FY | - CNY | 4.26% |
| 2018 Q2 | 0.19 CNY | 35.71% |
| 2018 Q3 | 0.15 CNY | -21.05% |
| 2017 Q3 | 0.11 CNY | -45.0% |
| 2017 Q1 | 0.12 CNY | -14.29% |
| 2017 Q2 | 0.20 CNY | 66.67% |
| 2017 FY | - CNY | 6.82% |
| 2017 Q4 | 0.15 CNY | 36.36% |
| 2016 Q2 | 0.15 CNY | 25.0% |
| 2016 Q1 | 0.12 CNY | 0.0% |
| 2016 Q3 | 0.12 CNY | -20.0% |
| 2016 Q4 | 0.14 CNY | 16.67% |
| 2016 FY | - CNY | -4.35% |
| 2015 Q1 | 0.12 CNY | 0.0% |
| 2015 Q2 | 0.12 CNY | 0.0% |
| 2015 FY | - CNY | 27.78% |
| 2014 FY | - CNY | 33.33% |
| 2013 FY | - CNY | -6.9% |
| 2012 FY | - CNY | 0.0% |